 Radical prostatectomy versus expectant primary treatment stages II prostatic cancer fifteen-year follow-up fifteen-year follow-up prospective study placebo radical prostatectomy primary treatment early prostatic cancer total patients clinical Stage II prostatic cancer normal acid phosphatase levels negative findings skeletal x-ray film evaluable Thirty Stage patients Stage II patients placebo Stage Stage II patients underwent radical prostatectomy survival status patients fifteen-year follow-up significant differences crude survival stage stages survival reference curves mortality men comparable ages races significant association high Gleason histologic score poor survival study initial treatment radical prostatectomy survival initial placebo treatment findings caution sample size small staging procedure